@Vivek_Investor Lockdown gave that chance people were twice productive working remotely, environment was clean as never before, greedy politicians and builder lobby destroyed it for their own benefits.
@JainDenesh वृत्तपत्रात विकु नये बंदी आहे, पेपर मध्ये 🌯 करून विकु नये अशी बंदी नाहीये. पेपर कप साठी बंदी नाहीये, बरेच लोकं त्याला प्रीफर करतात mcafee and CCD मध्ये पण पेपर कप मध्ये पेय देतात.
@Mavlemfrt@JainDenesh 2022 ला UPI वर कोणते चार्ज नसणार पासून आता लागायला लागले, तो पण निर्णय योग्य आणि हा पण योग्य, मग कधी तरी कोणी तर मूर्ख असेल का दोन्ही वेळा जणताच मूर्ख असणार चोम्या?
@malpani I complained about bag wt avg 4.5-6kg to principal of my daughter's school, she took my child in isolation weighed her bag nd found couple extra books, bt kept mum on why so much text books, workbooks and notebooks for Grade 2? For Her profit weighed more than students wellbeing.
The most expensive part of a hospital bill may never touch the hospital at all.
A patient admitted for care has no way of knowing whether the price on a medical consumable reflects its actual cost or a markup fixed long before it ever reached the ward. That gap in information is, at its core, a public health issue.
A survey of hospital consumables in Maharashtra found an IV infusion set with a trade price of ₹11.05 carrying a printed MRP of ₹325 ; a markup of 2,841%. A syringe procured at ₹6.75 carried an MRP of ₹57.20. A catheter procured at ₹29.41 carried an MRP of ₹310.
These are not elective purchases. Patients cannot compare prices, seek alternatives, or question a number printed on a box while receiving care and the MRP itself is often fixed upstream by manufacturers and distributors, disconnected from the trade price by a wide, unexplained margin. The result is a system where the party bearing the cost has the least information to evaluate it.
The regulatory gap is structural: scheduled medicines are capped under the Drugs (Prices Control) Order, 2013. Most medical devices and consumables are not leaving both the pricing and the information around it almost entirely unmonitored.
A review of these findings and clear guidelines on the permissible gap between trade procurement price and declared MRP have been recommended to the Department of Pharmaceuticals and the NPPA ; a step toward closing not just a pricing gap, but the information gap patients are left to bear alone.
#PublicHealth #GoodGovernance #Leadership #TukaramMundhe
https://t.co/Ye9CVzr8qU